Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    "retroperitoneal fibrosis"
Show Display Options
RSS Create an RSS feed from your search for:
"retroperitoneal fibrosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
Condition: Retroperitoneal Fibrosis
Interventions: Drug: Tamoxifen;   Drug: Prednisone
2 Unknown  Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial
Conditions: Idiopathic Retroperitoneal Fibrosis;   Perianeurysmal Retroperitoneal Fibrosis;   Chronic Periaortitis
Interventions: Drug: Methotrexate+Prednisone;   Drug: Prednisone
3 Completed Rituximab in IgG4-related Disease: A Phase 1-2 Trial
Conditions: Retroperitoneal Fibrosis;   Autoimmune Pancreatitis;   Sialadenitis;   Pseudotumor
Intervention: Drug: Rituximab
4 Recruiting Treatment of IgG4-Related Disease With Revlimid and Rituximab
Conditions: Immunoglobulin G Subclass 4 Related Disease;   IgG4-related Disease;   Autoimmune Pancreatitis;   IgG4-related Sclerosing Cholangitis;   Retroperitoneal Fibrosis
Interventions: Drug: Rituximab;   Drug: Lenalidomide
5 Recruiting Leflunomide for Maintenance of Remission in IgG4 Related Disease
Condition: Immunoglobulin G4 Related Sclerosing Disease
Interventions: Drug: Prednisone;   Drug: Leflunomide

Study has passed its completion date and status has not been verified in more than two years.